MUMBAI, India, June 26 -- Intellectual Property India has published a patent application (202617067098 A) filed by Xenon Pharmaceuticals Inc. on May 28, 2026, for Substituted Aryl Sulfonamides For Use As Sodium Channel Inhibitors.
Inventors include Charifson, Paul S.; Clark, Michael Philip; Gilbert, James; Jackson, Stephen; Hambira, Chido M.; Burford, Kristen; Clement, Helen; Kim, Jung Yun; Lofstrand, Verner Alexander; and Boyd, Michael J..
The application for the patent was published on June 19, 2026, under issue no. 25/2026.
Abstract: The present disclosure provides compounds having Formula I: and the pharmaceutically acceptable salts, solvates, and stereoisomers thereof, wherein M1, M2, M3, M4, Z, n, R5, R6, W, A, and R9 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to inhibit sodium channels (e.g., Nav1.7) and/or to treat a disorder responsive to the inhibition of a sodium channel (e.g., Nav1.7). Compounds of the present disclosure may be useful for treating pain.
Disclaimer: Curated by HT Syndication.
